Literature DB >> 29607122

Who benefit most from catheter ablation of persistent atrial fibrillation?

Yuki Komatsu1, Kazutaka Aonuma1.   

Abstract

Entities:  

Year:  2018        PMID： 29607122      PMCID： PMC5864610          DOI： 10.21037/jtd.2018.01.12

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation.

Authors:  Martin Fiala; Dan Wichterle; Veronika Bulková; Libor Sknouril; Renáta Nevralová; Ondrej Toman; Miloslav Dorda; Jaroslav Januska; Jindrich Spinar
Journal:  Europace       Date:  2013-07-12       Impact factor: 5.214

2.  Reversion of tachycardiomyopathy after beta-blocker.

Authors:  M P van den Berg; D J van Veldhuisen; H J Crijns; K I Lie
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

3.  A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

Authors:  Ross J Hunter; Thomas J Berriman; Ihab Diab; Ravindu Kamdar; Laura Richmond; Victoria Baker; Farai Goromonzi; Vinit Sawhney; Edward Duncan; Stephen P Page; Waqas Ullah; Beth Unsworth; Jamil Mayet; Mehul Dhinoja; Mark J Earley; Simon Sporton; Richard J Schilling
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-01

Review 4.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

5.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

6.  Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Jonathan S Steinberg; Ara Sadaniantz; Jack Kron; Andrew Krahn; D Marty Denny; James Daubert; W Barton Campbell; Edward Havranek; Katherine Murray; Brian Olshansky; Gearoid O'Neill; Magdi Sami; Stanley Schmidt; Randle Storm; Miguel Zabalgoitia; John Miller; Mary Chandler; Elaine M Nasco; H Leon Greene
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

7.  Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.

Authors:  Luigi Di Biase; Prasant Mohanty; Sanghamitra Mohanty; Pasquale Santangeli; Chintan Trivedi; Dhanunjaya Lakkireddy; Madhu Reddy; Pierre Jais; Sakis Themistoclakis; Antonio Dello Russo; Michela Casella; Gemma Pelargonio; Maria Lucia Narducci; Robert Schweikert; Petr Neuzil; Javier Sanchez; Rodney Horton; Salwa Beheiry; Richard Hongo; Steven Hao; Antonio Rossillo; Giovanni Forleo; Claudio Tondo; J David Burkhardt; Michel Haissaguerre; Andrea Natale
Journal:  Circulation       Date:  2016-03-30       Impact factor: 29.690

8.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

Authors:  David G Jones; Shouvik K Haldar; Wajid Hussain; Rakesh Sharma; Darrel P Francis; Shelley L Rahman-Haley; Theresa A McDonagh; S Richard Underwood; Vias Markides; Tom Wong
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

Review 9.  Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.

Authors:  Hugh Calkins; Matthew R Reynolds; Peter Spector; Manu Sondhi; Yingxin Xu; Amber Martin; Catherine J Williams; Isabella Sledge
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06-02

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.